Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Short dental implants could spare patients from bone grafting

NCT ID NCT07162389

Disease control Sponsor: University of Science and Technology, Yemen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study compares how stable short (7mm) and standard (11mm) dental implants are during the first 4 weeks after placement in the lower jaw. Ten adults with missing back teeth and limited bone height will receive one of the two implant types. The goal is to see if short implants can be a good option without needing bone grafting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dental implant
What this could lead to
If successful, short implants could offer a less invasive option for people with limited jawbone, reducing the need for bone grafting.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to everyone. There are typical surgery risks like swelling, infection, and rare nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Adults ≥18 years with partial posterior mandibular edentulism. 2. Bone height ≥7 mm and width \>6 mm (CBCT-confirmed). 3. D2/D3 bone density (HU: 350-1250). 4. Healed posterior mandibular sites (3-6 months post-extraction). 5. Good oral hygiene (plaque index ≤1). 6. Willingness to adhere to study protocols. Exclusion Criteria: * 1\. Uncontrolled systemic diseases (e.g., diabetes with HbA1c \>7%, liver disease) or medications affecting bone healing (e.g., corticosteroids, bisphosphonates). 2\. History of head/neck radiotherapy (with in past year). 3. Heavy smoking (\>10 cigarettes/day). 4. Absolute contraindications for oral surgery (e.g., recent MI/CVA \< 6months, bleeding disorders). 5\. Active periodontal disease, parafunctional habits as bruxism, or prior bone grafting at the site.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alveolar bone atrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alveolar Bone Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alveolar bone atrophy

Contacts and locations

Locations

  • university of Sciences and Technology

    Sanaa, 009671, Yemen

More trials for these conditions

Other studies related to the condition(s) this trial covers.